Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 0520204 trials

STCUBE

Official website

Biopharma and cosmetics distributor behind the BTN1A1-targeting immuno-oncology drug Nelmastobart and cosmetics brand Scenearth.

As of 2026-10-10, STCUBE has 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1989 and listed on KOSDAQ in 2001, the company operates both a biopharma segment (immuno-oncology and antibody therapeutics) and a cosmetics distribution business. It holds the immuno-oncology drug Nelmastobart (BTN1A1-targeting, first-in-class) and its in-house cosmetics brand Scenearth. Current-period revenue is about 92% from cosmetics sales/distribution and 8% from industrial lens modules; Nelmastobart received its Phase 1 CSR in September 2024 and Phase 2 IND approval from Korea's MFDS in October 2025.

Products & technology

  • ScenearthIn-house cosmetics brand
  • industrial lens moduleDistributed to domestic companies

Clinical trials

data.go.kr

4 MFDS clinical trial authorisations · 2022–2025 (Phase 1/2 2 · Phase 2 1 · Phase 1 1)

  • Phase 2넬마스토바트2025-10-16

    5 trial sites

  • Phase 1/2넬마스토바트2025-03-20

    5 trial sites

  • Phase 1/2넬마스토바트2023-09-21

    6 trial sites

  • Phase 1넬마스토바트2022-03-15

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

넬마스토바트(Nelmastobart) · 고형암(소세포폐암→비소세포폐암 전환), 전이성 대장암 · 임상2상 IND 승인(2025.10) · First-in-class BTN1A1-targeting immuno-oncology drug; concurrent Korea/US Phase 1 approval in 2022; Phase 1 CSR received Sep 2024; Phase 1b/2 sponsor-initiated trial approved Mar 2025; Phase 2 IND approved for NSCLC Oct 2025

Key disclosures

KRX KIND via OpenDART
Show 2 more events

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 36 more patents

AI reads

MAA server logs · IP-verified
84
Times AI engines pulled STCUBE's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

6
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

78
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
58
live 1
Last 30 days
84
live 6
All time
  • OpenAIChatGPT-Userlive6
  • OpenAIOAI-SearchBot70
  • PerplexityPerplexityBot4
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for STCUBE and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryBiotech & Drug Discovery

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

Inventage Lab Inc.100

Drug delivery system company behind the long-acting injectable platform IVL-DrugFluidic and the LNP delivery platform IVL-GeneFluidic.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

SK Chemicals Co., Ltd.85

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

CG Invites Co., Ltd.85

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

Y-Biologics, Inc85

KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.

GC Corp.85

A holding company overseeing 54 affiliates including its main biopharmaceutical subsidiary GC, with no direct product manufacturing of its own.

Prestige BioPharma Limited85

Founded in 2015 and listed on KOSPI in 2021, Prestige BioPharma develops antibody biosimilars and novel antibody drugs including Tuznue.

GENEMATRIX INC.85

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

SillaJen, Inc.85

SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.

SK Bioscience Co.,Ltd84

A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition